Ipca Laboratories consolidated net profit rises 37.95% in the December 2024 quarter
Net profit of Ipca Laboratories rose 37.95% to Rs 248.14 crore in the quarter ended December 2024 as against Rs 179.88 crore during the previous quarter ended December 2023. Sales rose 9.38% to Rs 2245.37 crore in the quarter ended December 2024 as against Rs 2052.85 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 2245.37 | 2052.85 | 9 |
| OPM % | 20.62 | 16.12 | - |
| PBDT | 466.38 | 319.93 | 46 |
| PBT | 367.92 | 220.43 | 67 |
| NP | 248.14 | 179.88 | 38 |
